Susquehanna International Group, LLP Selecta Biosciences Inc Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $131,005 - $256,100	98,500 New	98,500 $162,000
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $34,071 - $91,687	-27,700 Reduced 46.24%	32,200 $40,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $823,072 - $1.26 Million	-284,800 Reduced 82.62%	59,900 $195,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $165,984 - $228,228	49,400 Added 16.73%	344,700 $1.43 Million
Q2 2021 Aug 11, 2021	SELL	$2.82 - $5.01 $385,494 - $684,867	-136,700 Reduced 31.64%	295,300 $1.23 Million
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $1.17 Million - $2.04 Million	401,700 Added 1325.74%	432,000 $1.96 Million
Q4 2020 Feb 16, 2021	SELL	$1.64 - $3.42 $23,780 - $49,590	-14,500 Reduced 32.37%	30,300 $92,000
Q3 2020 Nov 16, 2020	BUY	$2.18 - $2.84 $15,914 - $20,732	7,300 Added 19.47%	44,800 $111,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $4.06 $33,855 - $75,110	18,500 Added 97.37%	37,500 $107,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $28,500 - $85,879	19,000 New	19,000 $46,000
Q4 2019 Feb 14, 2020	SELL	$1.32 - $2.47 $39,600 - $74,100	-30,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.6 - $2.08 $48,000 - $62,400	30,000 New	30,000 $53,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.